CTLA4 and neoplasm: Given that CTLA-4, PD-1, and LAG-3 exert inhibitory effects on DCs and T cells via distinct mechanisms of action, it was hypothesized that simultaneously blocking multiple signals could potentially amplify the anti-tumor response.